366
Participants
Start Date
October 29, 2009
Primary Completion Date
July 1, 2010
Study Completion Date
July 1, 2010
Fluticasone propionate/salmeterol combination product
Fluticasone propionate/salmeterol combination product 250/50mcg DISKUS twice a day for 8 weeks
Salmeterol
Salmeterol 50mcg DISKUS twice a day for 8 weeks
Placebo
Placebo DISKUS twice a day for 8 weeks
GSK Investigational Site, Erie
GSK Investigational Site, Philadelphia
GSK Investigational Site, Richmond
GSK Investigational Site, Abingdon
GSK Investigational Site, Elizabeth City
GSK Investigational Site, Charlotte
GSK Investigational Site, Spartanburg
GSK Investigational Site, Clinton
GSK Investigational Site, Gaffney
GSK Investigational Site, Easley
GSK Investigational Site, Greenwood
GSK Investigational Site, Seneca
GSK Investigational Site, Chester
GSK Investigational Site, Decatur
GSK Investigational Site, Lawrenceville
GSK Investigational Site, Tamarac
GSK Investigational Site, Jasper
GSK Investigational Site, Mobile
GSK Investigational Site, Johnson City
GSK Investigational Site, Madisonville
GSK Investigational Site, Canton
GSK Investigational Site, Cincinnati
GSK Investigational Site, South Bend
GSK Investigational Site, Evansville
GSK Investigational Site, Evansville
GSK Investigational Site, St Louis
GSK Investigational Site, New Orleans
GSK Investigational Site, Sunset
GSK Investigational Site, Houston
GSK Investigational Site, New Braunfels
GSK Investigational Site, Wheat Ridge
GSK Investigational Site, Riverside
GSK Investigational Site, Lake Oswego
GSK Investigational Site, Portland
GSK Investigational Site, Spokane
GSK Investigational Site, Los Angeles
GSK Investigational Site, Stamford
GSK Investigational Site, Summit
GSK Investigational Site, Charleston
Lead Sponsor
GlaxoSmithKline
INDUSTRY